Skip to content

When lactate speaks: Rewiring astrocyte-neuron metabolism in Alzheimer's disease.

Aug 2026 · Cell Metabolism · Vol 38 8, pp. 1527-1528 · 0 citations · 8 references
Medicine

TL;DR

It is shown that a brain-penetrant GLP-1 receptor agonist rewires astrocyte-neuron metabolic coupling through lactate-driven histone lactylation, linking astrocytic glycolysis to neuronal lipid homeostasis and positioning metabolite signaling as a therapeutic axis in neurodegeneration.

Abstract

Metabolic dysfunction is a defining but poorly understood feature of Alzheimer's disease. Du et al. show that a brain-penetrant GLP-1 receptor agonist rewires astrocyte-neuron metabolic coupling through lactate-driven histone lactylation, linking astrocytic glycolysis to neuronal lipid homeostasis and positioning metabolite signaling as a therapeutic axis in neurodegeneration.

View source

Similar papers

Aug 2026

The Microglia-Astrocyte-Neuron Lactate Shuttle model.

In a recent study, Adler and colleagues demonstrated that microglia regulate blood glucose delivery to fuel the astrocyte-neuron lactate shuttle. As neuronal protein translation supported by this mechanism is essential for motor learning, these findings reveal how coordinated interactions among microglia, astrocytes, a...

E. Zimmer, Anne-Karine Bouzier-Sore, Luc Pellerin · 0 citations
Sep 2026

Glucose hypometabolism gates tau-dependent necroptosis.

Tau pathology closely tracks neuronal loss in Alzheimer's disease, but how phosphorylated tau becomes lethal has remained unclear. Chen et al. identify a dual-hit mechanism: glucose hypometabolism removes a protective A20-mediated brake on necroptosis while phosphorylated tau scaffolds RIPK1 activation, driving tau-ass...

M. Sassano, B. de Strooper · 0 citations
Review Open access Sep 2026

Brain energy metabolism in neurodegenerative disease.

The brain is a highly complex organ composed of diverse, specialized cell types whose coordinated functions underpin cognition and behavior. While extensive research has elucidated neuronal signaling mechanisms, the metabolic interactions between distinct brain cells that sustain energy homeostasis are not yet comprehe...

Carmen Lahr, Elle Wilson, Melanie Sengupta et al. · 0 citations
Open access Sep 2026

ENT1 inhibition links oligodendrocyte lipid metabolism to connectivity in tauopathy

Metabolic dysfunction, altered adenosine signaling, and white matter abnormalities are implicated in tauopathies, but their relationship to network disconnection remains unclear. Myelinating oligodendrocytes may represent a metabolically vulnerable hub linking these processes to circuit dysfunction.

Ching-Pang Chang, Ching-Wen Chang, Ching-Wen Wu et al. · 0 citations
Open access Sep 2026

The Alzheimer's disease risk gene SORL1 is a regulator of excitatory neuronal function

Synaptic dysfunction is an early feature of Alzheimer's disease (AD) and proper localization of proteins involved in pre‐ and post‐synaptic composition is dependent on endosomal recycling and trafficking, cellular processes involving the AD risk gene sortilin‐related receptor 1 (SORL1).

C. Williams, Shannon E. Rose, Vera Stamenković et al. · 0 citations
Aug 2026

STINGing the brain: S-nitrosylation drives neuroinflammation in Alzheimer's disease.

It is demonstrated that S-nitrosylation of the cyclic GMP-AMP synthase (cGAS) stimulator of interferon genes (STING) pathway sustains pathological neuroinflammation in AD, identifying a promising therapeutic target for this devastating disease.

A. A. Pieper, Emiko Miller, O. Khalimonchuk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.